Clinical Trial Detail

NCT ID NCT03384836
Title Propranolol Hydrochloride and Pembrolizumab in Treating Patients With Stage IIIC-IV Melanoma That Cannot Be Removed by Surgery
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Roswell Park Cancer Institute
Indications

melanoma

Therapies

Pembrolizumab + Propranolol

Age Groups: adult senior

No variant requirements are available.